Edition:
India

People: Bio Rad Laboratories Inc (BIO.N)

BIO.N on New York Stock Exchange

559.40USD
4 Dec 2020
Change (% chg)

$6.13 (+1.11%)
Prev Close
$553.27
Open
$555.94
Day's High
$561.97
Day's Low
$549.81
Volume
86,195
Avg. Vol
52,523
52-wk High
$648.39
52-wk Low
$315.00

Daskal, Ilan 

Mr. Ilan Daskal serves as Chief Financial Officer, Executive Vice President of the Company effective April 6, 2019. He was appointed Executive Vice President and Chief Financial Officer, effective April 6, 2019. Prior to joining Bio-Rad, Mr. Daskal, was the Chief Financial Officer of Lumileds, a global leader in advanced lighting technology, from May 2017 to January 2019. From 2015 through 2016, Mr. Daskal held multiple short-term Chief Financial Officer roles with private and public companies including Aricent Inc., a global design and engineering company, Cepheid, a molecular diagnostic company, and SunEdison Inc., a renewable energy company. Prior to that, from 2008 to 2015, Mr. Daskal was the Executive Vice President and Chief Financial Officer at International Rectifier Corporation, a leader in power management semi-conductor technology that was publicly traded until it was acquired by Infineon Technologies in 2015. Mr. Daskal also currently serves on the Board of Directors of Natus Medical Incorporated, a publicly traded provider of medical device solutions.

Basic Compensation

Total Annual Compensation, USD 621,644
Restricted Stock Award, USD 1,084,440
Long-Term Incentive Plans, USD --
All Other, USD 300,675
Fiscal Year Total, USD 2,006,760

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

Norman Schwartz

7,261,050

Ilan Daskal

2,006,760

Andrew Last

2,734,760

Timothy Ernst

--

Michael Crowley

1,826,290

Giovanni Magni

1,026,400
As Of  31 Dec 2019